• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.

作者信息

Bauer L A, Blouin R A

出版信息

Clin Pharmacokinet. 1983 Nov-Dec;8(6):545-9. doi: 10.2165/00003088-198308060-00006.

DOI:10.2165/00003088-198308060-00006
PMID:6653035
Abstract

The Michaelis-Menten pharmacokinetic parameters Vmax and Km were calculated for 135 epileptic paediatric patients receiving phenytoin as their only anticonvulsant therapy. Mean Vmax and Km values were 13.95 mg/kg/day and 6.59 micrograms/ml for 0.5 to 3-year-old patients, 10.93 mg/kg/day and 6.82 micrograms/ml for the 4 to 6 year age group, 10.05 mg/kg/day and 6.51 micrograms/ml for the 7 to 9-year-olds, and 8.25 mg/kg/day and 5.69 micrograms/ml for the 10 to 16 year group. Using analysis of variance, the Vmax values were significantly different (p less than 0.01) but the Km values were not. Linear regression analysis of Vmax versus age revealed a significant decline in Vmax with age (r = -0.554; p less than 0.001). A plot of Km versus age showed a poor correlation (r = -0.170) and a large amount of variability. Based on this data, the youngest age group would require on average 62% more phenytoin/kg/day than the oldest age group in order to maintain a steady-state phenytoin concentration of 15 micrograms/ml. Because of these age-related pharmacokinetic differences, phenytoin dosages may require adjustment as paediatric patients become older.

摘要

相似文献

1
Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.
Clin Pharmacokinet. 1983 Nov-Dec;8(6):545-9. doi: 10.2165/00003088-198308060-00006.
2
Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
Int J Clin Pharmacol Ther Toxicol. 1989 Apr;27(4):173-8.
3
Age and phenytoin kinetics in adult epileptics.
Clin Pharmacol Ther. 1982 Mar;31(3):301-4. doi: 10.1038/clpt.1982.37.
4
Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
Ther Drug Monit. 1984;6(1):11-4.
5
Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients.
Pediatr Pharmacol (New York). 1980;1(2):171-80.
6
Phenytoin dosage requirements and pharmacokinetic variables.
Clin Pharm. 1983 May-Jun;2(3):253-7.
7
Phenytoin--allopurinol interaction: Michaelis--Menten kinetic parameters of phenytoin with and without allopurinol in a child with Lesch--Nyhan syndrome.
Ther Drug Monit. 1982;4(4):353-7.
8
Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient.
J Pediatr. 1980 Mar;96(3 Pt 1):479-84. doi: 10.1016/s0022-3476(80)80705-0.
9
Interindividual variation in the extent and rate of phenytoin accumulation.
Ther Drug Monit. 1987 Jun;9(2):171-6. doi: 10.1097/00007691-198706000-00008.
10
Pharmacokinetics of phenytoin in children.苯妥英钠在儿童体内的药代动力学。
Br J Clin Pharmacol. 1981 Nov;12(5):659-61. doi: 10.1111/j.1365-2125.1981.tb01285.x.

引用本文的文献

1
The Fundamentals of Antiseizure Medications: A Through Z.抗癫痫药物基础:从A到Z
Epilepsy Curr. 2024 Oct 7:15357597241281838. doi: 10.1177/15357597241281838.
2
Therapeutic hypothermia decreases phenytoin elimination in children with traumatic brain injury.治疗性低温会降低颅脑损伤儿童中苯妥英的消除率。
Crit Care Med. 2013 Oct;41(10):2379-87. doi: 10.1097/CCM.0b013e318292316c.
3
Bayesian forecasting in paediatric populations.儿科人群中的贝叶斯预测

本文引用的文献

1
Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin.临床及脑电图与血清苯妥英水平的相关性
Arch Neurol. 1960 Jun;2:624-30. doi: 10.1001/archneur.1960.03840120030004.
2
Inter-ethnic and inter-phenotype differences among Ghanaians and Caucasians in the metabolic hydroxylation of phenytoin [proceedings].加纳人和高加索人在苯妥英代谢羟化方面的种族间和表型间差异[会议记录]
Br J Clin Pharmacol. 1980 Mar;9(3):282P-283P. doi: 10.1111/j.1365-2125.1980.tb04842.x.
3
Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient.
Clin Pharmacokinet. 1996 Nov;31(5):325-30. doi: 10.2165/00003088-199631050-00001.
4
Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.抗癫痫药物治疗的优化。血清药物浓度监测的重要性。
Clin Pharmacokinet. 1996 Aug;31(2):120-30. doi: 10.2165/00003088-199631020-00004.
5
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.抗癫痫药物在儿科患者中的临床药代动力学。第二部分。苯妥英、卡马西平、舒噻美、拉莫三嗪、氨己烯酸、奥卡西平和非氨酯。
Clin Pharmacokinet. 1995 Nov;29(5):341-69. doi: 10.2165/00003088-199529050-00004.
6
Phenytoin dosage predictions in paediatric patients.小儿患者苯妥英钠的剂量预测
Clin Pharmacokinet. 1989 Apr;16(4):254-60. doi: 10.2165/00003088-198916040-00004.
7
Therapeutic drug monitoring of phenytoin. Rationale and current status.苯妥英钠的治疗药物监测。基本原理与现状。
Clin Pharmacokinet. 1990 Nov;19(5):341-58. doi: 10.2165/00003088-199019050-00001.
8
Nonlinear pharmacokinetics: clinical Implications.非线性药代动力学:临床意义。
Clin Pharmacokinet. 1991 Jun;20(6):429-46. doi: 10.2165/00003088-199120060-00001.
9
Bayesian parameter estimation and population pharmacokinetics.
Clin Pharmacokinet. 1992 Jun;22(6):447-67. doi: 10.2165/00003088-199222060-00004.
J Pediatr. 1980 Mar;96(3 Pt 1):479-84. doi: 10.1016/s0022-3476(80)80705-0.
4
Pharmacokinetics of phenytoin in children.苯妥英钠在儿童体内的药代动力学。
Br J Clin Pharmacol. 1981 Nov;12(5):659-61. doi: 10.1111/j.1365-2125.1981.tb01285.x.
5
Phenytoin and phenobarbitone plasma level-dose relationships in Chinese epileptic children in Singapore.新加坡华裔癫痫儿童苯妥英钠和苯巴比妥的血药浓度-剂量关系
Ther Drug Monit. 1981;3(3):247-52. doi: 10.1097/00007691-198103000-00004.
6
Differences in single dose phenytoin kinetics between Greenland Eskimos and Danes.
Ther Drug Monit. 1981;3(3):239-45. doi: 10.1097/00007691-198103000-00003.
7
Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.群体药代动力学参数估算方法的评估。I. 米氏模型:常规临床药代动力学数据。
J Pharmacokinet Biopharm. 1980 Dec;8(6):553-71. doi: 10.1007/BF01060053.
8
Nonlinear kinetics of phenytoin in children.苯妥英钠在儿童体内的非线性动力学
Neurology. 1982 Jan;32(1):42-8. doi: 10.1212/wnl.32.1.42.
9
Steady-state pharmacokinetics of phenytoin from routinely collected patient data.
Clin Pharmacokinet. 1983 Jul-Aug;8(4):355-64. doi: 10.2165/00003088-198308040-00006.
10
Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.气液色谱法快速测定血浆中的苯妥英
Anal Chem. 1970 Mar;42(3):421-2. doi: 10.1021/ac60285a024.